Safety and effectiveness of antiretroviral therapies for HIV-infected women and their infants and children: protocol for a systematic review and network meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2046-4053
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Safety and effectiveness of antiretroviral therapies for HIV-infected women and their infants and children: protocol for a systematic review and network meta-analysis ; volume:3 ; number:1 ; day:25 ; month:5 ; year:2014 ; pages:1-6 ; date:12.2014
Systematic Reviews ; 3, Heft 1 (25.5.2014), 1-6, 12.2014
- Creator
-
Tricco, Andrea C.
- Contributor
-
Antony, Jesmin
Angeliki, Veroniki A.
Ashoor, Huda
Hutton, Brian
Hemmelgarn, Brenda R.
Moher, David
Finkelstein, Yaron
Gough, Kevin
Straus, Sharon E.
SpringerLink (Online service)
- DOI
-
10.1186/2046-4053-3-51
- URN
-
urn:nbn:de:1111-2016071825375
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tricco, Andrea C.
- Antony, Jesmin
- Angeliki, Veroniki A.
- Ashoor, Huda
- Hutton, Brian
- Hemmelgarn, Brenda R.
- Moher, David
- Finkelstein, Yaron
- Gough, Kevin
- Straus, Sharon E.
- SpringerLink (Online service)
Other Objects (12)
How can we improve the interpretation of systematic reviews?
Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis
Correction: Characteristics of ‘mega’ peer-reviewers
Characteristics of ‘mega’ peer-reviewers
Guidelines for randomized clinical trial protocol content: a systematic review
Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis
Reporting guidelines for realist evaluations seek to improve clarity and transparency
Reporting guidelines: doing better for readers
Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review
Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: Protocol for a systematic review and network meta-analysis
Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis
Comparative safety of anti-epileptic drugs among infants and children exposed in utero or during breastfeeding: protocol for a systematic review and network meta-analysis
How can we improve the interpretation of systematic reviews?
Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis
Correction: Characteristics of ‘mega’ peer-reviewers
Characteristics of ‘mega’ peer-reviewers
Guidelines for randomized clinical trial protocol content: a systematic review
Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis
Reporting guidelines for realist evaluations seek to improve clarity and transparency
Reporting guidelines: doing better for readers
Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review
Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: Protocol for a systematic review and network meta-analysis
Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis
Comparative safety of anti-epileptic drugs among infants and children exposed in utero or during breastfeeding: protocol for a systematic review and network meta-analysis
How can we improve the interpretation of systematic reviews?
Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis
Correction: Characteristics of ‘mega’ peer-reviewers
Characteristics of ‘mega’ peer-reviewers
Guidelines for randomized clinical trial protocol content: a systematic review
Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis
Reporting guidelines for realist evaluations seek to improve clarity and transparency
Reporting guidelines: doing better for readers
Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review
Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: Protocol for a systematic review and network meta-analysis
Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis